Hikma Pharmaceuticals (HIK)

Sector: Pharma and Biotech     Index: FTSE 100
1.45%
24.00p
1,680.00p
17:20 23/05/17
1,680.00p
17:20 23/05/17
DAILY VARIATION
1.45%
24.00p
VOLUME
1,054,037
REAL TIME BATS
1,689.00p
17:36 23/05/17
2.05%
34.00p
DATA
52 Week High
2,676.00p
52 Week Low
1,624.00p
Shares Issued
240.27m
Market Cap
£4,036.47m
RiskGrade
n/a
Beta
1.32
MENU

Hikma Pharmaceuticals Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 1.5% 1.7%
Div Cover 3.6 3.7
Op Mrgn 15.5% 18.2%
ROCE 19.3%
Latest F'cast
P/E 18.4 18.5
PEG -1.0 1.1
Pr/Revenue 2.7 2.3
Pr/Book 2.2
Latest F'cast
Revenue 35.4% 2.5%
PBT -34.0% n/a
EPS -17.5% -9.8%
DPS 3.1% 14.7%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2012-12-31 1,109.00 132.00 61.40¢ 20.2 1.1 18% 16.00¢ 1.3%
2013-12-31 1,365.00 298.00 139.10¢ 14.3 0.1 127% 20.00¢ 1.0%
2014-12-31 1,489.00 362.00 151.00¢ 20.4 2.4 9% 22.00¢ 0.7%
2015-12-31 1,440.00 318.00 143.70¢ 23.6 -4.9 -5% 32.00¢ 0.9%
2016-12-31 1,950.00 210.00 118.50¢ 19.7 -1.1 -18% 33.00¢ 1.4%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 1,766.13 321.59 104.64p 18.5 1.2 15% 28.11p 1.5%
2018-12-31 1,931.78 400.25 134.14p 14.9 0.5 28% 32.94p 1.7%

Regulatory News

slide to see more
Result of AGM 19-May-17 14:45
Trading Statement 19-May-17 07:02
Director/PDMR Shareholding 15-May-17 15:30

Newspaper Links

slide to see more